Brief: FibroGen Announces Approval Of Sale Of Fibrogen China To Astrazeneca By The China State Administration For Market Regulation
18/08/2025 14:43
Aug 18 (Reuters) - FibroGen Inc FGEN.O: FIBROGEN ANNOUNCES APPROVAL OF SALE OF FIBROGEN CHINA TO ASTRAZENECA BY THE CHINA STATE ADMINISTRATION FOR MARKET REGULATION FIBROGEN INC - SALE OF FIBROGEN CHINA ON TRACK TO CLOSE IN 3Q 2025 Source text: ID:nGNXfpy23 Further company coverage: FGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyntra Bio
See all newsBrief: Kyntra Bio Appoints Andrew E. Singer, Mba To Its Board Of Directors
NASDAQ RESUMED AT 01:28 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:23 PM
Kyntra Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kyntra Bio swings to profit in Q2 on deconsolidation of subsidiary